These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. FIBRINOLYTIC AND ESTEROLYTIC ACTIVITY OF HUMAN PLASMA. ADAMIS DM; MANIATIS GM Thromb Diath Haemorrh; 1965 Jun; 13():484-91. PubMed ID: 14347870 [No Abstract] [Full Text] [Related]
5. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY]. DOUGLAS AS; MCNICOL GP Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145 [No Abstract] [Full Text] [Related]
6. Effects of epsilon-amino-caproic acid on prolactin-inactivating and fibrinolytic activities of streptokinase-activated plasminogen. HOPKINS TF; MEITES J Proc Soc Exp Biol Med; 1963 Apr; 112():830-2. PubMed ID: 13961684 [No Abstract] [Full Text] [Related]
7. THROMBOLYTIC THERAPY. DOUGLAS AS; MCNICOL GP Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954 [No Abstract] [Full Text] [Related]
8. RADIOACTIVE (I-125) HUMAN PLASMA CLOTS FOR ASSAY OF THROMBOLYTIC ACTIVITY. HUME M J Lab Clin Med; 1964 Apr; 63():699-702. PubMed ID: 14155458 [No Abstract] [Full Text] [Related]
9. CURRENT STATUS OF THROMBOLYTIC THERAPY. SHERRY S Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883 [No Abstract] [Full Text] [Related]
10. [THE PROACTIVATOR OF THE FIBRINOLYTIC SYSTEM IN VENOUS BLOOD OF THE UMBILICAL CORD AND OF OLDER INFANTS]. KUENZER W; MARKEL A Ann Paediatr; 1964; 202():278-84. PubMed ID: 14135039 [No Abstract] [Full Text] [Related]
11. SOME CONSIDERATIONS IN THE SYSTEMIC USE OF FIBRINOLYTIC AGENT. COON WW Mich Med; 1964 Jul; 63():488-90. PubMed ID: 14182774 [No Abstract] [Full Text] [Related]
12. FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE). JAMES DC; BROWSE NL Br J Clin Pract; 1964 Jun; 18():343-56. PubMed ID: 14169065 [No Abstract] [Full Text] [Related]
13. [THE CURRENT STATUS OF FIBRINOLYTIC THERAPY]. KAPPERT A Med Klin; 1963 Nov; 58():1844-6. PubMed ID: 14100260 [No Abstract] [Full Text] [Related]
15. THE FIBRINOLYTIC SYSTEM DURING THE MENSTRUAL CYCLE. BELLER FK; GOEBELSMANN U; DOUGLAS GW; JOHNSON A Obstet Gynecol; 1964 Jan; 23():12-6. PubMed ID: 14110046 [No Abstract] [Full Text] [Related]
16. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS. BACK N; HIRAMOTO R; AMBRUS JL Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764 [No Abstract] [Full Text] [Related]
17. FIBRINOLYTIC THERAPY IN MENINGITIS AND VENTRICULITIS. STEWART GT J Clin Pathol; 1964 May; 17(3):355-9. PubMed ID: 14159482 [No Abstract] [Full Text] [Related]
18. THE QUANTITATIVE DETERMINATION OF FIBRINOLYTIC INHIBITORS IN PLASMA OR SERUM BY MEANS OF THE FIBRIN PLATE. BLIX S Scand J Clin Lab Invest; 1964; 16():403-8. PubMed ID: 14202020 [No Abstract] [Full Text] [Related]
19. THE CASEINOLYTIC METHOD FOR DETERMINATION OF PLASMINOGEN-PLASMIN IN HUMAN PLASMA AND SERUM. JACOBSEN CD Scand J Clin Lab Invest; 1964; 16():372-82. PubMed ID: 14202017 [No Abstract] [Full Text] [Related]
20. [THERAPEUTIC FIBRINOLYSIS. I. STUDIES ON THE EFFECTS OF STREPTOKINASE AND ACTASE IN VITRO]. JUERGENS J Klin Wochenschr; 1964 Jun; 42():534-8. PubMed ID: 14233281 [No Abstract] [Full Text] [Related] [Next] [New Search]